Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 385,200 | 394,700 | 192,500 | 360,400 | 311,800 |
| Cost of Goods | 120,200 | 129,800 | 76,900 | 132,900 | 108,000 |
| Gross Profit | 265,000 | 264,900 | 115,600 | 227,500 | 203,800 |
| Operating Expenses | 203,900 | 139,700 | 128,100 | 150,800 | 133,100 |
| Operating Income | 61,300 | 126,000 | -11,600 | 77,600 | 70,700 |
| Interest Expense | 7,600 | 6,400 | 8,600 | 9,000 | 10,300 |
| Other Income | 1,300 | 1,100 | -1,100 | 2,800 | -1,500 |
| Pre-tax Income | 55,000 | 120,700 | -21,300 | 71,400 | 58,900 |
| Income Tax | 15,500 | 28,000 | -8,800 | 24,600 | 15,700 |
| Net Income Continuous | 39,500 | 92,700 | -12,500 | 46,800 | 43,200 |
| Net Income | $39,500 | $92,700 | $-12,500 | $46,800 | $43,200 |
| EPS Basic Total Ops | 0.75 | 1.76 | -0.24 | 0.91 | 0.84 |
| EPS Basic Continuous Ops | 0.75 | 1.76 | -0.24 | 0.91 | 0.84 |
| EPS Diluted Total Ops | 0.73 | 1.73 | -0.24 | 0.90 | 0.83 |
| EPS Diluted Continuous Ops | 0.73 | 1.73 | -0.24 | 0.91 | 0.83 |
| EBITDA(a) | $91,000 | $155,400 | $17,300 | $106,300 | $99,100 |